Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
来曲唑、节拍式环磷酰胺和索拉非尼联合用药耐受性良好,对原发性乳腺癌患者有效。
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/bjc.2014.563
Bazzola, L; Foroni, C; Andreis, D; Zanoni, V; R Cappelletti, M; Allevi, G; Aguggini, S; Strina, C; Milani, M; Venturini, S; Ferrozzi, F; Giardini, R; Bertoni, R; Turley, H; Gatter, K; Petronini, P G; Fox, S B; Harris, A L; Martinotti, M; Berruti, A; Bottini, A; Reynolds, A R; Generali, D